隐藏的危险:静脉注射添加剂中的微塑料及其进入身体的途径
Anushree Pal1, Sukalyan Chakraborty2
1Department of Civil and Environmental Engineering, Birla Institute of Technology, Ranchi, Jharkhand, 835215, India.
Environmental monitoring and assessment
|March 16, 2025
概括
微塑料 (MP) 存在于储存在塑料袋中的医疗IV液体中. 长时间储存会增加MP的污染,在医疗治疗期间可能对健康构成风险.
科学领域:
- 环境科学 环境科学
- 材料科学 材料科学 材料科学
- 公共卫生 公共卫生
背景情况:
- 微塑料 (MPs) 的污染在环境领域和人体组织中广泛存在.
- 已知MP在商业产品中的来源,但其在医疗治疗中的存在尚未得到充分研究.
- 静脉注射 (IV) 添加剂储存在塑料容器中,引发了对潜在的MP漏的担忧.
研究的目的:
- 调查静脉注射 (IV) 添加剂中微塑料的存在和特征.
- 为了确定存储时间是否会影响塑料IV容器中的MP释放.
- 为了确定在IV溶液中发现的构成MP的聚合物类型.
主要方法:
- 使用立体显微镜检测和量化MP的11种IV添加剂的分析.
- 使用微福里埃变换红外光谱 (FTIR) 进行MP大小,形态 (纤维和碎片) 和聚合物组成的表征.
- MP 丰度与储存时间和容器表面状况的相关性.
主要成果:
- 在所有分析的IV添加剂中检测到MPs的显著存在,主要是纤维和碎片 (<100μm).
- 已识别的聚合物包括聚烯-聚乙烯 (PP-PE) 共聚合物,聚烯 (PP) 同聚合物,聚烯 (PVP) 和聚氨 (PU).
- 随着更长的储存时间,观察到增加的MP丰度和容器表面粗度,表明材料降解.
结论:
- 输液添加剂代表了微塑料直接进入人体的被忽视的暴露途径.
- 储存期间塑料容器的降解有助于医学溶液的MP污染.
- 由于IV治疗的广泛使用,对健康风险和监管措施的进一步研究至关重要.
更多相关视频
05:31Sampling, Sorting, and Characterizing Microplastics in Aquatic Environments with High Suspended Sediment Loads and Large Floating Debris
Published on: July 28, 2018
15.9K
05:48Sampling, Identification and Characterization of Microplastics Release from Polypropylene Baby Feeding Bottle during Daily Use
Published on: July 24, 2021
5.5K
相关概念视频
Prevention of Further Absorption of Poison
777
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
777
Types of Toxins
1.6K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.6K
Drug Distribution: Tissue Binding
2.5K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.5K
Routes of Drug Administration: Parenteral
1.8K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
1.8K
